Alzheimer's Disease Clinical Trials

A listing of Alzheimer's Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
Gait Monitoring Study.

The purpose of the study is to learn about the gait characteristics of persons with Alzheimer’s disease and related dementias (ADRD). We also want to understand how we should design and implement a tool to monitor gait.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Validation Study of a Sensor for Monitoring Sleep.

The study aims to research people with Alzheimer’s Disease and other forms of cognitive impairment, and their caregivers and family members, that suffer from various forms of sleep disturbance.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Indiana Memory & Aging Study

The purpose of this study is to use brain imaging and genetic biomarkers, cognitive and sensory testing and behavior ratings to study memory processing as it relates to aging in the brain.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Indiana Alzheimer Disease Core Center

The purpose of this program is to identify, evaluate, study, and follow persons who have Alzheimer?s disease, those who have other disorders of memory and thinking, and older individuals who have normal memory and thinking.

  • 0 views
  • 19 Feb, 2024
  • 1 location
The Presence Study- Studying the Effect of LY3154207 on Cognition in Mild-to-Moderate Parkinson's Disease Dementia (PDD)

The purpose of this study is to determine how LY3154207 compares with placebo in treating memory and thinking problems in individuals with mild-to-moderate Parkinson?s disease dementia.

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Phase 1 Study to Evaluate the Safety and Tolerability of a Study Drug in Subjects with Early Alzheimer's Disease (AD)

This study will test the safety and tolerability of an experimental study drug that may delay Alzheimer’s disease (AD) onset or slow the progression of possible AD-related damage due to protein build-up in the brain.   Methods include measuring the amount of study drug and drug-related material in the cerebrospinal fluid …

  • 0 views
  • 19 Feb, 2024
  • 1 location
DEcisions about Cancer screening in Alzheimer's Disease (DECAD)

The purpose of this study is to gain an understanding about the use of educational pamphlets by caregivers of women with dementia. This study will randomly assign caregivers to receive one of two different educational pamphlets and is designed to gather information on how caregivers make health care decisions for …

  • 0 views
  • 19 Feb, 2024
  • 1 location
Dominantly Inherited Alzheimer Network (DIAN)

The overall purpose of this research is to understand the changes that occur in dominantly inherited Alzheimer disease.

  • 0 views
  • 19 Feb, 2024
  • 1 location
Development of a Research Registry for Possible Participation in Future Research Studies Conducted Within the IU Center for Alzheimer's Disease and Related Disorders

The purpose of this Registry is to capture contact and personal health information data for self-referred volunteers and established clinical patients in the Indiana University Alzheimer's Disease and Related Disorders Center with the diagnosis of Probable Alzheimer's disease, Mild Cognitive Impairment, Lewy Body Disease, Frontal Temporal Dementia, Vascular Dementia and …

  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

BAN2401 is an investigational study drug which is being studied in people who have early AD (Alzheimer's disease), with mild cognitive (thinking) impairment or mild dementia. People with AD have a build-up of abnormal protein known as amyloid in their brains.

  • 0 views
  • 19 Feb, 2024
  • 1 location